Contraindications to Metoprolol Succinate
Metoprolol succinate is absolutely contraindicated in patients with severe bradycardia, heart block greater than first degree (without a pacemaker), cardiogenic shock, decompensated cardiac failure, sick sinus syndrome (without a permanent pacemaker), and hypersensitivity to any component of the product. 1
Absolute Contraindications
The FDA label clearly defines the following as absolute contraindications 1:
- Severe bradycardia - any heart rate that is severely reduced
- Heart block greater than first degree - second- or third-degree AV block without a permanent pacemaker in place 2
- Cardiogenic shock - acute state of inadequate cardiac output 2
- Decompensated cardiac failure - acute heart failure with signs of volume overload or low output 2
- Sick sinus syndrome - unless a permanent pacemaker is in place 1
- Hypersensitivity - to metoprolol or any component of the formulation 1
Conditions Requiring Extreme Caution (Not Absolute Contraindications)
Active Bronchospasm
Active asthma or reactive airway disease with active bronchospasm is a contraindication 2, though the guidelines distinguish this from stable chronic obstructive pulmonary disease (COPD) or asthma history. Patients with chronic lung disease or asthma history without active bronchospasm can receive beta-1 selective agents like metoprolol succinate at low doses with careful monitoring 2. The key distinction is active versus stable disease - active bronchospasm is a true contraindication, while stable COPD/asthma is not 2.
Hypotension
Significant hypotension (systolic BP <90 mm Hg or >30 mm Hg below baseline) requires caution 2, but is not an absolute contraindication. Mild or transient reductions in blood pressure should not preclude use 2. The 2022 ACC/AHA/HFSA guidelines emphasize that oral GDMT should not be withheld for mild blood pressure reductions 2.
Risk Factors for Cardiogenic Shock
In acute coronary syndromes, intravenous beta-blockers are potentially harmful in patients with risk factors for shock 2, including:
- Age >70 years
- Heart rate >110 bpm or <60 bpm
- Systolic BP <120 mm Hg
- Late presentation after symptom onset 2
However, oral metoprolol succinate can still be initiated cautiously in these patients once stabilized 2.
Common Pitfalls to Avoid
Do not confuse relative contraindications with absolute contraindications. Many clinicians inappropriately withhold metoprolol succinate in patients with:
- Stable COPD or asthma history (without active bronchospasm) - beta-1 selective agents are safe 2, 3
- Mild hypotension - should not preclude therapy 2
- Mild worsening renal function - not a contraindication 2
- Older age alone - age is not a contraindication 4
The only true absolute contraindications are those listed in the FDA label 1: severe bradycardia, high-degree heart block without pacemaker, cardiogenic shock, decompensated heart failure, sick sinus syndrome without pacemaker, and drug hypersensitivity.